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Background: The majority of familial hypertrophic cardiomyopathy (HCM) (70%) is caused by mutations in 2 sarcomere genes, MYH7 and 
MYBPC3. Prognosis of patients with a MYH7 mutation is worse compared with MYBPC3 patients, but no pathophysiological mechanism causing this 
outcome has yet been unravelled. We investigated if myocardial regional function differs between pre-hypertrophic MYH7 (MYH7mut) and MYBPC3 
(MYBPC3mut) mutation carriers using cardiovascular magnetic resonance.
methods: Magnetic resonance cine imaging was performed in 6 MYH7mut (1 male, 36±12 years) and 18 MYBPC3mut (5 males, 35±13 years) to 
determine left ventricular mass, ejection fraction and end-diastolic wall thickness (EDWT) according to the 17-segment model of the American Heart 
Association. Myocardial tissue tagging was used to calculate peak systolic circumferential strain (SCS).
results: Left ventricular mass index and ejection fraction were comparable between MYH7mut and MYBPC3mut (respectively, 52±6 vs 48±10 g/
m2 and 61±2 vs 59±5%). Despite slightly larger EDWT in MYH7mut, regional SCS was significantly higher in all segments in MYH7mut compared with 
MYBPC3mut (figure 1)
conclusions: Although MYH7 and MYBPC3 mutations both ultimately result in HCM, peak SCS is higher in MYH7 compared with MYBPC3 carriers 
before the development of hypertrophy. This apparent different mutation-effect on myocardial function might partly explain the difference in disease 
onset between HCM caused by the thick filament mutations.
 
